Equinatoxin II: How a Cationic Pore-Forming Sea Anemone Toxin Drives Nodal Swelling of Myelinated Nerve Fibers
Marine Drugs · 21.05.2026 · 24 (5) · 187
DOI: 10.3390/md24050187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 21.05.2026. Verfasst von Evelyne Benoit und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Ingénierie Moléculaire Pour la Santé (SIMoS), EMR CNRS 9004, Département Médicaments et Technologies Pour la Santé (DMTS), Institut des Sci…. Hauptthemen laut MEDLINE: Cnidarian Venoms, Nerve Fibers, Myelinated, Sea Anemones. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Bilateral Slovenian/French Proteus Program, Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
This study was performed to elucidate the mechanism underpinning the nodal swelling induced by equinatoxin II (EqtII), a cation-selective pore-forming toxin derived from the sea anemone Actinia equina. Experiments were conducted using frog myelinated nerve fibers as a model system. Application of EqtII led to an approximately two-fold increase in the nodal volume of myelinated axons, but only when extracellular Ca2+ was present. Replacing extracellular Cl− with isethionate had no measurable effect on this response, whereas substitution of NaCl with either sucrose or LiCl, an established Na+/Ca2+ exchanger (NCX) inhibitor, abolished the swelling. The persistence of the effect in the presence of tetrodotoxin indicates that voltage-gated Na+ channels are not involved in the underlying mechanism. Our data suggest that Ca2+ influx through EqtII-induced membrane pores raises intracellular Ca2+ levels, thereby stimulating the NCX in its forward-operating mode. This process promotes Ca2+ extrusion in exchange for Na+ entry. The resulting accumulation of intracellular Na+ increases osmotic pressure within the axon, leading to water influx and nodal swelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Ingénierie Moléculaire Pour la Santé (SIMoS), EMR CNRS 9004, Département Médicaments et Technologies Pour la Santé (DMTS), Institut des Sciences du Vivant Frédéric Joliot, Commissariat à l'énergie atomique et…
- Institute of Preclinical Sciences, Veterinary Faculty, University of Ljubljana, Gerbičeva 60, S-1000 Ljubljana, Slovenia.
- UMR CNRS 9197, Institut des Neurosciences Paris-Saclay (NeuroPSI), Université Paris-Saclay, F-91400 Saclay, France.
- Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, School of Biomedical Sciences, The University of Queensland, St Lucia, QLD 4072, Australia.
- Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, S-1000 Ljubljana, Slovenia.
ORCID-Profile: Evelyne Benoit, Robert Frangež, Frédéric A Meunier, Dusan Šuput, Jordi Molgó
Förderung
- The Slovenian Research and Innovation Agency
- Bilateral Slovenian/French Proteus Program
- Slovenian Research and Innovation Agency
- National Centre for Scientific Research
- French Alternative Energies and Atomic Energy Commission
Zitieren
APA
Benoit, E., Frangež, R., Ouanounou, G., Meunier, F. A., Šuput, D., & Molgó, J. (2026). Equinatoxin II: How a Cationic Pore-Forming Sea Anemone Toxin Drives Nodal Swelling of Myelinated Nerve Fibers. Marine Drugs, 24(5), 187. https://doi.org/10.3390/md24050187
Vancouver
Benoit E, Frangež R, Ouanounou G, Meunier FA, Šuput D, Molgó J. Equinatoxin II: How a Cationic Pore-Forming Sea Anemone Toxin Drives Nodal Swelling of Myelinated Nerve Fibers. Marine Drugs. 2026;24(5):187. doi:10.3390/md24050187
BibTeX
@article{Benoit2026,
author = {Benoit, Evelyne and Frangež, Robert and Ouanounou, Gilles and Meunier, Frédéric A and Šuput, Dusan and Molgó, Jordi},
title = {Equinatoxin II: How a Cationic Pore-Forming Sea Anemone Toxin Drives Nodal Swelling of Myelinated Nerve Fibers},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {5},
pages = {187},
doi = {10.3390/md24050187}
}
EUVIMED